Brief: Nicox Says Vyzulta Now Commercialized In 7 Territories And Approved In Further 9 Countries
23/02/2022 06:42
Feb 23 (Reuters) - Nicox SA NCOX.PA :
* NICOX ANNOUNCES VYZULTA NOW COMMERCIALIZED IN 7
TERRITORIES AND
APPROVED IN FURTHER 9 COUNTRIES
* RECEIVES INCREASING TIERED ROYALTIES OF 6% TO 12% ON NET
GLOBAL
SALES OF VYZULTA AND IS ENTITLED TO RECEIVE A $20 MILLION
MILESTONE PAYMENT1 UPON VYZULTA NET SALES REACHING $100 MILLION
* MAINTAINS PATENTS FOR LATANOPROSTENE BUNOD, AND U. S.
PATENT AND
TRADEMARK OFFICE RECENTLY DETERMINED THAT THREE U.S. COMPOSITION
OF MATTER PATENTS COVERING LATANOPROSTENE BUNOD ARE ELIGIBLE FOR
PATENT TERM EXTENSION, POTENTIALLY THROUGH TO 2030
Source text for Eikon: ID:nGNE8W3Vhy
Further company coverage: NCOX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))